Departments of Pharmacognosy, Medicinal Chemistry, Geology and Geological Engineering, National Center for Natural Products Research, and Departments of Pharmacology, Chemistry, and Biochemistry, School of Pharmacy, The University of Mississippi, University, MS 38677.
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):16832-7. doi: 10.1073/pnas.1311528110. Epub 2013 Sep 30.
One in five of the world's plant species is threatened with extinction according to the 2010 first global analysis of extinction risk. Tilman et al. predicted a massive ecological change to terrestrial plants within the next 50-100 y, accompanied by an increase in the number of global plant species facing extinction [Tilman D, et al. (2001) Proc Natl Acad Sci USA 98(10):5433-5440]. Most of the drug-producing plant families contain endangered species never previously studied for their utility to human health, which strongly validates the need to prioritize protection and assessment of these fragile and endangered groups [Zhu F, et al. (2011) Proc Natl Acad Sci USA 108(31):12943-12948]. With little prior attention given to endangered and rare plant species, this report provides strong justification for conservation of the rare plant Diplostephium rhododendroides Hieron., as well as other potential drug-producing endangered species in this and other groups.
根据 2010 年对灭绝风险的首次全球分析,世界上五分之一的植物物种面临灭绝威胁。Tilman 等人预测,在未来 50-100 年内,陆地植物将发生大规模的生态变化,同时面临灭绝的全球植物物种数量将增加[Tilman D, 等人。(2001)Proc Natl Acad Sci USA 98(10):5433-5440]。大多数产生药物的植物科包含以前从未因其对人类健康的用途而研究过的濒危物种,这强烈证明需要优先保护和评估这些脆弱和濒危群体[Zhu F, 等人。(2011)Proc Natl Acad Sci USA 108(31):12943-12948]。由于对濒危和稀有植物物种的关注甚少,本报告强烈证明了保护稀有植物 Diplostephium rhododendroides Hieron. 以及该组和其他组中其他潜在的药用濒危物种的合理性。